Zevra Therapeutics

Zevra Therapeutics is a leading biotechnology research company dedicated to developing and delivering life-changing therapeutics for patients with significant unmet needs. Zevra Therapeutics is committed to innovation and excellence in the field of rare disease treatments. With a focus on scientific rigor and a deep understanding of the challenges in drug development, Zevra Therapeutics collaborates with key thought leaders, physicians, patients, care partners, and advocacy groups to drive clinical and regulatory development strategies.

Located at 1180 Celebration Boulevard, Celebration, FL 34747, US (Primary address), Zevra Therapeutics also maintains facilities at 101 Federal St, 29th Floor, Boston, Massachusetts 02110, US; 2500 Crosspark Road, Coralville, IA 52241, US; 2200 Kraft Drive, Blacksburg, VA 24060, US; and 1001 Pennsylvania Ave, NE, 13th Floor North, Washington, DC 20004, US. Zevra Therapeutics leverages its expertise to forge new pathways to success, overcoming complex development challenges and making much-needed therapies available to patients. The company's transparent narratives and common-sense perspective enable it to advance new therapies with the potential to bring meaningful improvement to patients’ lives.

Zevra Therapeutics is dedicated to pushing boundaries and advancing therapeutic options for those who need them most. Zevra Therapeutics’s commitment extends to improving patient outcomes and transforming lives through innovative therapies. We invite the manager of Zevra Therapeutics to create a customized and exclusive company showcase and product listing on our platform to further highlight your achievements and connect with a wider audience.